Skip to main content
WHAT WE DO
NEWS & EVENTS
PEOPLE
OPPORTUNITIES
WEISER DIPLOMACY CENTER
Breadcrumb
Home
EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge
In the Media
EpiPen maker Mylan, Pfizer's Upjohn off-patent drug business to merge
August 20, 2019
USA Today
Marianne Udow-Phillips
Share: